Antiretroviral therapies and cardiovascular risk: True or false?

Affiliations

¹ Metabolic Clinic, Infectious and Tropical Diseases Unit, Department of Medicine, University of Modena and Reggio Emilia, Italy. Electronic address: giovanni.guaraldi@unimore.it.
² Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada.

Editorial

Giovanni Guaraldi et al. Atherosclerosis. 2017 Aug.

. 2017 Aug:263:313-314.

doi: 10.1016/j.atherosclerosis.2017.05.032. Epub 2017 May 27.

¹ Metabolic Clinic, Infectious and Tropical Diseases Unit, Department of Medicine, University of Modena and Reggio Emilia, Italy. Electronic address: giovanni.guaraldi@unimore.it.
² Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada.

No abstract available

Keywords: Darunavir; HIV; IMT.

Comment on

Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort.
Maggi P, Bellacosa C, Leone A, Volpe A, Ricci ED, Ladisa N, Cicalini S, Grilli E, Viglietti R, Chirianni A, Bellazzi LI, Maserati R, Martinelli C, Corsi P, Celesia BM, Sozio F, Angarano G. Maggi P, et al. Atherosclerosis. 2017 Aug;263:398-404. doi: 10.1016/j.atherosclerosis.2017.05.004. Epub 2017 May 5. Atherosclerosis. 2017. PMID: 28522147